CBPO [China Biologic Products] 6-K: (Original Filing)
[]
CBPO [China Biologic Products] 6-K: FOR RELEASE July 2, 2018 China Biologic Announces
[FOR RELEASE July 2, 2018 China Biologic Announces Results of Its 2018 Annual General Meeting of Shareholders BEIJING, China — July 2, 2018 — At the Annual Meeting, shareholders of the Company approved the re-election of each of Mr. Yungang Lu and Mr. Zhijun Tong as a Class III director to serve on t]
CBPO [China Biologic Products] 6-K: (Original Filing)
[FOR RELEASE July 2, 2018 China Biologic Announces Results of Its 2018 Annual General Meeting of Shareholders BEIJING, China — July 2, 2018 — At the Annual Meeting, shareholders of the Company approved the re-election of each of Mr. Yungang Lu and Mr. Zhijun Tong as a Class III director to serve on t]
CBPO [China Biologic Products] 6-K: (Original Filing)
[FOR RELEASE June 19, 2018 China Biologic Announces Receipt of Non-Binding Acquisition Proposal BEIJING, China — June 19, 2018 — About China Biologic Products Holdings, Inc. China Biologic Products Holdings, Inc. (NASDAQ: CBPO) is a leading fully integrated plasma-based biopharmaceutical company in C]
CBPO [China Biologic Products] 6-K: FOR RELEASE June 19, 2018 China Biologic Announces
[FOR RELEASE June 19, 2018 China Biologic Announces Receipt of Non-Binding Acquisition Proposal BEIJING, China — June 19, 2018 — About China Biologic Products Holdings, Inc. China Biologic Products Holdings, Inc. (NASDAQ: CBPO) is a leading fully integrated plasma-based biopharmaceutical company in C]
CBPO [China Biologic Products] SC 13D: (Original Filing)
[CUSIP No. G21515104 JOINT FILING AGREEMENT Agreement 1. Each person executing this Agreement is responsible for the timely filing of such Schedule 13D and any subsequent amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but no pers]
CBPO [China Biologic Products] SC 13D: CUSIP No. G21515104 JOINT FILING AGREEMENT Agreement 1.
[CUSIP No. G21515104 JOINT FILING AGREEMENT Agreement 1. Each person executing this Agreement is responsible for the timely filing of such Schedule 13D and any subsequent amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but no pers]
